Position
Squarepoint Ops LLC in ArriVent BioPharma, Inc.
Back to the book · All holders of AVBP
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $163.5K$20.12 → $23.07
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 186.5K | $3.75M | — | — | — | 0.0% |
| Q1 2026 | 55.4K | $1.28M | $23.07 | $163.5K | −$2.64M | 0.0% |